RAPT Therapeutics Inc.

NASDAQ: RAPT · Real-Time Price · USD
11.70
0.45 (4.00%)
At close: Aug 15, 2025, 3:07 PM

RAPT Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a 1.53M 3.81M
Cost of Revenue
n/a 3.55M 2.81M 996K
Gross Profit
n/a -3.55M -1.28M 2.82M
Operating Income
-136.1M -127.06M -85.8M -69.21M
Interest Income
n/a n/a n/a n/a
Pretax Income
-129.87M -116.8M -83.84M -69.2M
Net Income
-129.87M -116.8M -81.88M -68.21M
Selling & General & Admin
28.88M 26.06M 20.24M 16.04M
Research & Development
107.22M 101M 67.08M 56.98M
Other Expenses
n/a n/a 1.96M 5K
Operating Expenses
136.1M 127.06M 87.32M 73.02M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 127.06M 87.32M 73.02M
Income Tax Expense
n/a n/a -1.96M -996K
Shares Outstanding (Basic)
40.76M 38.34M 32.54M 27.39M
Shares Outstanding (Diluted)
40.76M 38.34M 32.54M 27.39M
EPS (Basic)
-3.19 -3.05 -2.52 -2.49
EPS (Diluted)
-3.19 -3.05 -2.52 -2.49
EBITDA
-126.33M -125.85M -84.75M -68.21M
EBIT
-129.87M -127.06M -85.8M -69.21M
Depreciation & Amortization
3.54M 1.22M 2.81M 996K